Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|January 27, 2025
Evolutionary trajectories of immune escape across cancersWenjie Chen, Toby Baker, Zhihui Zhang, et al.Science Advances|October 14, 2022
Machine learning on syngeneic mouse tumor profiles to model clinical immunotherapy responseZexian Zeng, Shengqing Stan Gu, Cheryl J Wong, et al.Nature Communications|May 6, 2023
MetaTiME integrates single-cell gene expression to characterize the meta-components of the tumor immune microenvironmentYi Zhang, Guanjue Xiang, Alva Yijia Jiang, et al.Cancer Immunology Research|October 11, 2022
Hippo Signaling Pathway Regulates Cancer Cell-Intrinsic MHC-II ExpressionZexian Zeng, Shengqing Stan Gu, Nofal Ouardaoui, et al.Cell|September 28, 2021
In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy targetXiaoqing Wang, Collin Tokheim, Shengqing Stan Gu, et al.Genome Biology|October 16, 2020
Clonal tracing reveals diverse patterns of response to immune checkpoint blockadeShengqing Stan Gu, Xiaoqing Wang, Xihao Hu, et al.Cancer Discovery|February 6, 2023
Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor AlphaAvinash Sahu, Xiaoman Wang, Phillip Munson, et al.Cancer Discovery|February 16, 2021
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint BlockadeShengqing Stan Gu, Wubing Zhang, Xiaoqing Wang, et al.The Journal of Clinical Investigation|December 24, 2024
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer modelsDezhi Li, Ke Geng, Yuan Hao, et al.Journal of Translational Medicine|February 21, 2024
A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancerMike Mason, Óscar Lapuente-Santana, Anni S Halkola, et al.Pageof 1